Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Theaflavin Alleviates Inflammatory Response and Brain Injury Induced by Cerebral Hemorrhage via Inhibiting the Nuclear Transcription Factor Kappa β-Related Pathway in Rats [Retraction]
Fu G, Wang H, Cai Y, Zhao H, Fu W. Drug Des Devel Ther. 2018;12:1609–1619.
The Editor and Publisher of Drug Design, Development and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of western blot bands in Figure 3D. The authors explained that an error had been made by the journal which led to the unintended duplication of the Caspase-1 and IL-1β bands in Figure 3D. The journal accepts an error was made, however further investigation found the authors were unable to provide adequate original western blot data and could no longer verify the validity of the reporting findings. The decision was made to retract the article and the authors do not agree with this.
We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.